pharmaphorum

SEPTEMBER 22, 2021

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

Pharma Companies 109

Pharma Companies Life Science Development Production 109

pharmaphorum

AUGUST 18, 2020

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and providing more value in closing the care gap, the report says. The impact on launch.

Pharma Companies 128

Pharma Companies Sales Life Science Marketing 128

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 129

Branding Marketing Pharma Companies Life Science 129

World of DTC Marketing

JANUARY 24, 2022

Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? VCs invest money in biotech because they see a potential windfall via a profitable acquisition or sale, but when the FDA weighs in with delays, VCs can be ruthless. not necessarily. Only about $2.2

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

DECEMBER 6, 2023

This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% Life cycle adjustment A life cycle adjustment will not be introduced, which has been welcomed by the industry. in 2024, 24% in 2025 and 26.8% in Spain and 8.25% in Ireland.

Life Science 59

Life Science Branding Medicine Pharma Companies 59

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Nevertheless, the advent of COVID-19 is forcing pharma, and many other sectors, to make some radical changes.

Regulation 97

Regulation Marketing Sales Branding 97

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 Veeva is the global leader in cloud software for the life sciences industry. Download the whitepaper here: [link].

Marketing 52

Marketing Life Science Compliance Pharma Companies 52

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. Many new therapeutics are needed to treat the broad range of bacterial infections, and bringing new antibiotics to market is both difficult and expensive.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

JANUARY 21, 2021

86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a greater volume of content now, compared to six months ago. To assist executives in life sciences with scaling marketing assets in a virtual world Veeva has published a new eBook, Powering Omnichannel Strategies with Modular Content.

Life Science 70

Life Science Marketing Compliance Sales 70

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 98

Life Science Gene Therapy Gene Editing Gene 98

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Rather than simply surviving, the life sciences industry needs to respond proactively. Make it easy for the sales team.

Life Science 103

Life Science Sales Pharma Companies Production 103

pharmaphorum

JANUARY 19, 2021

A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. More pharma companies are moving in this direction, and 78% of respondents said they are undertaking, or planning, a customer data enhancement initiative.

Sales 102

Sales Pharma Companies Life Science Production 102

pharmaphorum

MARCH 9, 2021

Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. To thrive in this environment, pharma needs to move from ad-hoc and reactionary digital transformation to long-term ‘digital excellence’, says Veeva’s Sebastien Noel. Market pressures. Achieving digital excellence.

Sales 130

Sales Doctors Doctor Marketing 130

pharmaphorum

NOVEMBER 3, 2021

Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content. New content does not need to be rewritten.

Pharma Companies 98

Pharma Companies Life Science Marketing Branding 98

pharmaphorum

DECEMBER 7, 2021

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them.

Life Science 104

Life Science Pharma Companies Branding Marketing 104

pharmaphorum

APRIL 19, 2022

In 2022, pharma is truly a global industry, and innovation can come from anywhere. But for small life sciences outside of the USA and Europe, it can still be challenging to break onto this global stage. The company recently raised $16.5 So] we are trying to go for the international market.”. “In

Marketing 52

Marketing Clinical Trials Clinical Trials Licensing 52

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Pharma marketers need to educate oncologists on available treatment options that keep up with the constant updates to standards of care. “In

Branding 98

Branding Marketing Life Science Pharma Companies 98

pharmaphorum

JANUARY 5, 2023

Like many industries, the pharmaceutical labour market has felt and will continue to feel the impacts of the COVID-19 pandemic moving into 2023 and beyond. A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies. Final takeaway.

Life Science 90

Life Science Pharmacy Marketing Sales 90

Pharma Marketing Network

MARCH 29, 2022

Pharmaceutical companies have been successful for decades with a siloed marketing strategy. Rep-led field engagement, television advertising, and digital marketing have all been planned, executed, and measured separately, but customer expectations are changing fast.

Marketing 52

Marketing Pharma Companies Sales Life Science 52

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 97

Life Science Compliance Production Pharma Companies 97

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form.

Life Science 67

Life Science Drugs Branding Medicine 67

Intouch Solutions

MARCH 2, 2023

A futurist by nature, he’s been interviewed by many life-sciences reporters in recent weeks, to help them come to terms with how AI can, will, and IS, changing pharma. ” “ Can ChatGPT Revolutionize Pharma Marketing? Here are a few clips from some of those conversations.

Marketing 52

Marketing Life Science Pharma Companies Sales 52

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Healthcare Provider (HCP) marketing.

Clinical Trials 102

Clinical Trials Clinical Trials Life Science Marketing 102

pharmaphorum

NOVEMBER 23, 2022

Innovative offerings around market access. A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients.

Life Science 98

Life Science Marketing Medicine Production 98

XTalks

NOVEMBER 2, 2023

Amgen and Johnson & Johnson struck a settlement in May in which Wezlana’s market launch will be delayed until January 1, 2025 in exchange for Johnson & Johnson dropping a patent infringement lawsuit against Amgen. billion in sales, accounting for ten percent of Johnson & Johnson’s revenue.

FDA Approval 59

FDA Approval Production Dermatology Sales 59

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. Building strong data foundations. ” says Hale.

Production 52

Production Sales Life Science Marketing 52

pharmaphorum

JANUARY 29, 2021

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. One of these companies is Omnipresence. I don’t think it’s possible to go back from this.

Life Science 125

Life Science Sales Marketing Pharma Companies 125

pharmaphorum

DECEMBER 2, 2020

Their follow-up to penicillin, Terramycin, first marketed in 1950, was both their first proprietary drug, and the first for which the company used sales reps, their soon to be formidable force of salesmen starting with just eight members. Antibiotics marked the transition to the modern Pfizer.

Sales 127

Sales Production Drugs Marketing 127

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division.

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

pharmaphorum

MARCH 18, 2021

Which sales representative or Medical Science Liaison likes taking call notes? Sales reps and med-legal will use this argument initially to resist change. In my opinion, sales reps will love this feature because they will get their notes automatically and HCPs are unlikely to care if it means they are better supported.

Sales 52

Sales Pharma Companies Engineer Life Science 52

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data. Revising legislation. Positive projections.

Drugs 52

Drugs Marketing Life Science Regulation 52

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113

pharmaphorum

MARCH 4, 2022

When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients.

Doctors 98

Doctors Doctor Branding Pharma Companies 98

pharmaphorum

JANUARY 7, 2021

In an April survey conducted by Reuters and Omnipresence, 1,363 senior professionals mostly working in pharma (82.8%) in the EMEA region (73%) and biotech, medtech/device or consumer health companies reported on how life sciences organisations were adapting to the ‘new normal’.

Life Science 80

Life Science Sales Marketing Pharma Companies 80

Pharma Business Blog

MARCH 16, 2022

Happy to share the following Article of Chemie Pharma Innovation with you (German only): [link]. Dr. Sandra Ragaz , Partner Leader Pharma & Life Science VAT Switzerland Tel: +41 58 792 44 69 sandra.ragaz@pwc.ch. Der Beitrag The Pharma Gamechanger erschien zuerst auf Welcome. Have a pleasant reading.

Life Science 52

Life Science Licensing Licensing Pharma Companies 52